TriagePath
An ER physician types a one-liner about a 62-year-old with chest heaviness and gets back the next three tests to order, ranked by diagnostic gain per dollar — not just whatever has the highest accuracy.
Front-line ER physicians and urgent-care providers seeing undifferentiated patients on tight budgets
- Single text box that accepts the triage narrative plus last-known vitals and labs from the EHR
- Next-test ranking with both diagnostic yield and out-of-pocket/dollar cost attached to each option
- Plain-English rationale citing which symptom drove each suggestion
- One-click export of the workup into the attending handoff note and the order set
A new GraphDx paper reports success rates jumping from 50–68% to 79–93% while cutting test costs 20–54% — the first published multi-agent framework that explicitly optimizes cost alongside accuracy, which is the metric ERs actually care about.
AI clinical decision support market is large and growing (~$1.8-4.8B in 2025-2026, ~17-22% CAGR) with a dedicated AI-in-ER segment, but evidence specifically tying ER physicians to a cost-per-diagnostic-gain workflow is mostly the GraphDx paper itself, not buyer behavior data.AI-Based Clinical Decision Support Services Market Size, Trends, Growth ↗AI In Emergency Room, Hospital Management Market 2026 ↗
Market is crowded with established and free competitors: Isabel Healthcare (incumbent, 'thousands of clinicians'), DxGPT (free for doctors), Smart Clinician, Medler, plus published ER-specific LLM systems — the cost-aware angle is novel but the symptom-in/diagnosis-out slot is already taken.Differential Diagnosis Tool | Isabel Healthcare ↗DxGPT: Free AI Diagnostic Support for Complex & Rare Diseases ↗AI Differential Diagnosis Assistant - Clinical Decision Support ↗
Proven subscription model exists (Isabel Pro has published tiered pricing and enterprise sales), CDSS budgets at hospitals are real, and 20%+ CAGR market growth supports pricing — offset by free tiers like DxGPT and the friction that ER physicians don't directly procure, hospital IT/EHR committees do.Individual Pricing - Isabel Healthcare ↗AI-Powered Clinical Decision Support Market Size, Share, and Industry Trends ↗
Healthcare cost pressure and value-based-care reimbursement tailwinds favor cost-aware tools long-term, and FDA-cleared CDSS builds a regulatory moat — but AI-in-healthcare regulatory shifts (e.g., evolving FDA/EMA software-as-medical-device guidance) and incumbent EHR-bundled features are real risks.Artificial Intelligence In Clinical Decision Support Market (2026 - 2033) ↗Isabel Healthcare: Pricing, Reviews & Features 2026 ↗
Requires FDA Class II software-as-medical-device clearance, prospective clinical validation, deep EHR integration (Epic/Cerner), and real-time latency budgets under seconds — GraphDx provides a research framework but no production-grade, regulated deployment exists yet, and clinical liability is severe.GraphDx: A Cost-Aware Knowledge-Enhanced Multi-Agent Framework for Sequential Diagnosis ↗Isabel Review 2026: Pricing & Features ↗